Erik Kline, Ph.D.
About Erik Kline, Ph.D.
Erik Kline, Ph.D., is an Executive Medical Science Liaison at Bristol-Myers Squibb, specializing in immunotherapies for various types of oncology in the Greater Atlanta Area.
Title
Erik Kline, Ph.D., is currently the Executive Medical Science Liaison at Bristol-Myers Squibb, based in the Greater Atlanta Area.
Company
Erik Kline is working at Bristol-Myers Squibb, where he provides medical education and clinical trial support on immunotherapies for melanoma, genitourinary (RCC/UC/prostate), and gastrointestinal (HCC/esophageal/gastric/CRC) oncology. His territory includes Mississippi, Alabama, Georgia, South Carolina, western Tennessee, and the Florida panhandle.
Education and Expertise
Erik Kline studied at Emory University, where he achieved his Ph.D. in Molecular & Systems Pharmacology between 2002 and 2008. He previously earned a B.S. in Microbiology and Cell Science from the University of Florida from 1997 to 2000. His expertise includes hematology, molecular/systems pharmacology, microbiology, and solid tumor Immuno-Oncology.
Background
Before assuming his role at Bristol-Myers Squibb, Erik Kline served as a Postdoctoral Fellow at the Winship Cancer Institute of Emory University from 2008 to 2012. He was also a Ph.D. Candidate at Emory University from 2000 to 2008. Additionally, he gained experience as an Intern Researcher at Glycorex AB in 2000 for a duration of four months.
Medical Science Liaison Activities
Erik Kline has supported medical science liaison activities across various oncology domains, including breast, lung, head-and-neck, glioblastoma, leukemia, and multiple myeloma oncology. His current focus is on solid tumor Immuno-Oncology.